These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 32931751)

  • 1. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
    Liu J; Xia X; Huang P
    Mol Ther; 2020 Nov; 28(11):2358-2366. PubMed ID: 32931751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus mutagenesis approach improves the thermal stability of system x
    Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O
    Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
    Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
    Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System Xc
    Liu MR; Zhu WT; Pei DS
    Invest New Drugs; 2021 Aug; 39(4):1123-1131. PubMed ID: 33506324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial Glutamate Transporter-Mediated Plasticity: System x
    Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.
    Zheng J; Sato M; Mishima E; Sato H; Proneth B; Conrad M
    Cell Death Dis; 2021 Jul; 12(7):698. PubMed ID: 34257282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
    Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
    Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
    Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.
    Yang Y; Yee D
    Cancer Res; 2014 Apr; 74(8):2295-305. PubMed ID: 24686172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
    Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
    Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I; Yoshimura SH; Katoh H
    J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
    Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
    Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
    Lee Y; Itahana Y; Ong CC; Itahana K
    J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.